Expression of Aberrant CD Markers in Acute Leukemia:Retrospective Study in South Egypt Cancer Institute

NCT03743909 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-11-16

No results posted yet for this study

Summary

* To determine incidence of Expression of aberrant CD markers in acute leukemia in South Egypt .
* Correlation between this expression and outcome of the patient.

Conditions

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-01-31
Completion
2021-04-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03743909 on ClinicalTrials.gov